Extracorporeal Photopheresis Improves Survival in Hematopoietic Cell Transplant Patients with Bronchiolitis Obliterans Syndrome without Significantly Impacting Measured Pulmonary Functions
Mehrdad Hefazi(Mayo Clinic), Mrinal M. Patnaik(Mayo Clinic), Jeffrey L. Winters(Mayo Clinic), Shahrukh K. Hashmi(Mayo Clinic), Mark E. Wylam(Mayo Clinic), Nandita Khera(Mayo Clinic in Florida), Hemang Yadav(Mayo Clinic in Arizona), Manish J. Gandhi(Mayo Clinic), Vivek Iyer(Johns Hopkins University), Rodrigo Cartin‐Ceba, William J. Hogan(Mayo Clinic), James G. Scott(Harborview Medical Center), Dennis A. Gastineau, Vivek Roy(Jacksonville College), Kimberly J. Langer(Mayo Clinic), Mark R. Litzow(Dana-Farber Cancer Institute), Justin D. Kreuter(Mayo Clinic), Eapen K. Jacob(Mayo Clinic), Jill Adamski(Mayo Clinic Hospital)
Cited by 34
Related Papers
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
|New England Journal of Medicine|2021|553
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
|Journal of Clinical Investigation|2020|485
Climate Change and Mental Health: A Scoping Review
|International Journal of Environmental Research and Public Health|2021|451
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435